Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Healthtrust
McKesson
Moodys
Harvard Business School
US Department of Justice

Generated: August 21, 2019

DrugPatentWatch Database Preview

Patent: 8,258,119

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,258,119
Title:Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers
Abstract: The present invention discloses triazene analogs of the general formula (I) and formula (II), their tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, and pharmaceutically acceptable salts thereof for the metastatic malignant melanoma and other cancers including but not limited to lymphomas, sarcomas, carcinomas, and gliomas. The invention further discloses a process for the preparation of the above said triazene analogs of formula (I) and formula (II), and their pharmaceutically acceptable compositions.
Inventor(s): Gokaraju; Ganga Raju (Andhra Pradesh, IN), Kasina; Sudhakar (Mercer Island, WA), Gokaraju; Rama Raju (Andhra Pradesh, IN), Golakoti; Trimurtulu (Andhra Pradesh, IN), Somepalli; Venkateswarlu (Andhra Pradesh, IN), Krishanu; Sengupta (Andhra Pradesh, IN), Bhupathiraju; Kiran (Andhra Pradesh, IN)
Assignee: Kasina Laila Innova Pharmaceuticals (Vijayawada, IN)
Application Number:12/559,811
Patent Claims:see list of patent claims

Details for Patent 8,258,119

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26   Try a Free Trial Kasina Laila Innova Pharmaceuticals (Vijayawada, IN) 2028-09-15 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26   Try a Free Trial Kasina Laila Innova Pharmaceuticals (Vijayawada, IN) 2028-09-15 RX search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18   Try a Free Trial Kasina Laila Innova Pharmaceuticals (Vijayawada, IN) 2028-09-15 RX Orphan search
Spectrum Pharms ZEVALIN ibritumomab tiuxetan INJECTABLE; INJECTION 125019 001 2002-02-19   Try a Free Trial Kasina Laila Innova Pharmaceuticals (Vijayawada, IN) 2028-09-15 RX Orphan search
Genzyme LEMTRADA alemtuzumab INJECTABLE;INJECTION 103948 003 2001-05-07   Try a Free Trial Kasina Laila Innova Pharmaceuticals (Vijayawada, IN) 2028-09-15 RX Orphan search
Genzyme CAMPATH alemtuzumab VIAL; INTRAVENOUS 103948 002 2001-05-07   Try a Free Trial Kasina Laila Innova Pharmaceuticals (Vijayawada, IN) 2028-09-15 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Baxter
Medtronic
Cipla
Fuji
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.